As the associated factors of EAF2, such as hypoxia-induced factor 1α (HIF-1α), PTEN, von Hippel–Lindau protein (pVHL), and p53, were identified in sequence, the network of the downstream pathways of EAF2 in prostate cancer would be gradually completed. This evidence concerns the gene TP53 and prostate cancer.